| Full Name | Seth Luoma |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapy |
| Experience | 13 Years |
| Location | 713 N Park St, Watertown, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104165950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XG0600X | Occupational Therapist - Gerontology | 0805 (South Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Progressive Therapy Llc | 4385054204 | 2 |
News Archive
Eating curcumin, a natural ingredient in the spice turmeric, may dramatically reduce the chance of developing heart failure, researchers at the Peter Munk Cardiac Centre of the Toronto General Hospital have discovered.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
Patients given a clot-busting drug following stroke appear to have better outcomes if they were already taking anti-platelet medications, despite an apparent increased risk for bleeding in the brain, according to an article posted online that will appear in the May 2008 print issue of Archives of Neurology.
Aetna announced that it has reached agreement with The Washington Hospital on a contract that adds a new hospital and potentially as many as 200 new physicians to Aetna's provider network in western Pennsylvania.
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
› Verified 8 days ago
| Provider Name | Sanford Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396764254 PECOS PAC ID: 0244143824 Enrollment ID: O20031110000532 |
News Archive
Eating curcumin, a natural ingredient in the spice turmeric, may dramatically reduce the chance of developing heart failure, researchers at the Peter Munk Cardiac Centre of the Toronto General Hospital have discovered.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
Patients given a clot-busting drug following stroke appear to have better outcomes if they were already taking anti-platelet medications, despite an apparent increased risk for bleeding in the brain, according to an article posted online that will appear in the May 2008 print issue of Archives of Neurology.
Aetna announced that it has reached agreement with The Washington Hospital on a contract that adds a new hospital and potentially as many as 200 new physicians to Aetna's provider network in western Pennsylvania.
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
› Verified 8 days ago
| Provider Name | Progressive Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1760089163 PECOS PAC ID: 4385054204 Enrollment ID: O20201104002718 |
News Archive
Eating curcumin, a natural ingredient in the spice turmeric, may dramatically reduce the chance of developing heart failure, researchers at the Peter Munk Cardiac Centre of the Toronto General Hospital have discovered.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
Patients given a clot-busting drug following stroke appear to have better outcomes if they were already taking anti-platelet medications, despite an apparent increased risk for bleeding in the brain, according to an article posted online that will appear in the May 2008 print issue of Archives of Neurology.
Aetna announced that it has reached agreement with The Washington Hospital on a contract that adds a new hospital and potentially as many as 200 new physicians to Aetna's provider network in western Pennsylvania.
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Seth Luoma, 713 N Park St, Watertown, SD 57201-1537 Ph: () - | Seth Luoma, 713 N Park St, Watertown, SD 57201-1537 Ph: (605) 881-8642 |
News Archive
Eating curcumin, a natural ingredient in the spice turmeric, may dramatically reduce the chance of developing heart failure, researchers at the Peter Munk Cardiac Centre of the Toronto General Hospital have discovered.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
Patients given a clot-busting drug following stroke appear to have better outcomes if they were already taking anti-platelet medications, despite an apparent increased risk for bleeding in the brain, according to an article posted online that will appear in the May 2008 print issue of Archives of Neurology.
Aetna announced that it has reached agreement with The Washington Hospital on a contract that adds a new hospital and potentially as many as 200 new physicians to Aetna's provider network in western Pennsylvania.
The U.S. Food and Drug Administration has scheduled a two-day public hearing on Nov. 2-3, 2010, on the implementation of the Biologics Price Competition and Innovation (BPCI) Act of 2009. The hearing will be held from 8:30 a.m. to 4:30 p.m. at the FDA's White Oak Campus, 10903 New Hampshire Ave., Building 31, room 1503, in Silver Spring, Md.
› Verified 8 days ago
Kelly Peters, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8 5th St Se, Watertown, SD 57201 Phone: 605-753-5400 Fax: 320-839-4196 | |
Elizabeth Marie Zemlicka, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 901 14th Ave Ne, Watertown, SD 57201 Phone: 605-954-4264 Fax: 605-799-1461 | |
Vitoria Heier, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7000 | |
Kimberely Dawn Ertelt, M.S. OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 401 9th Ave Nw, Watertown, SD 57201 Phone: 605-882-7000 Fax: 605-882-7636 | |
Big Stone Therapies Watertown, Llc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 8 5th St Se, Watertown, SD 57201 Phone: 605-753-5400 Fax: 605-753-6208 | |
Trusted Choice Services Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1134 Lincoln Ave Ne, Watertown, SD 57201 Phone: 605-881-1100 |